Arrowhead Pharmaceuticals (ARWR): filings, insider buys & geopolitical news
ARWR geopolitical news and exposure. ARWR appears in 0 Geopolitics Alpha notes. No notes are stored for this page yet.
Government contracts
No federal prime contract obligations are matched to Arrowhead Pharmaceuticals in USAspending.gov for the last five years, and no Department of Defense contract announcements name it in the past year. See the largest government contractors.
ARWR share price, last 12 months
Close $55.89 on Oct 16, 2026, +47.1% since Oct 24, 2025 (range $37.85 to $89.07, daily closes).
Company facts
- Ticker
- ARWR (NasdaqGS)
- Sector
- Health
- Industry (SEC SIC code)
- Pharmaceutical Preparations (2834)
Industry from the SEC Standard Industrial Classification code on the company's EDGAR filings.
What changed for Arrowhead Pharmaceuticals (ARWR)
- 0 news
- 0 SEC filings
- 0 fund / insider trades
Latest SEC filings
None on record yet.
Latest fund & insider buys and sales
None on record yet.
Held by superinvestors
2 of the tracked billionaire portfolios reported ARWR in their latest 13F, and 1 sold out. 13F data is delayed up to 45 days after quarter end; not advice.
| Manager | % of portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Howard Marks Oaktree Capital Management | 0.21% | $11.0M | New position | Q2 2026 |
| Dan Davidowitz Polen Capital Management | 0.01% | $538.9K | New position | Q2 2026 |
| Ray Dalio Bridgewater Associates | 0.00% | $0 | Sold out | Q2 2026 |
Latest geopolitical & market news
None on record yet.
Peers: Pharmaceutical Preparations
| Company | Ticker | Federal contracts, 12 months |
|---|---|---|
| Eli Lilly and | LLY | – |
| Johnson & Johnson | JNJ | – |
| AbbVie | ABBV | – |
| Merck | MRK | $2.5M |
| Novartis AG | NVS | – |
| AstraZeneca | AZN | – |
| Abbott Laboratories | ABT | $147.5M |
| Novo Nordisk A/S | NVO | – |
| Pfizer | PFE | -$122K |
| Vertex Pharmaceuticals | VRTX | – |
Biggest government contractors in Health: Regeneron Pharmaceuticals ($279.4M), Fresenius Medical Care AG ($236.7M), Emergent BioSolutions ($216.6M), DaVita ($154.5M), Abbott Laboratories ($147.5M), Amgen ($126.0M), Labcorp Holdings ($96.4M), Stryker ($92.5M).
Congressional trades in ARWR
Trades in ARWR that members of Congress have publicly reported, newest filing first.
No congressional trades are stored for this view yet.
All congressional stock trades →
Geopolitical news for ARWR
Everything on ARWR, newest first
No original notes are listed on this page yet.
Frequently asked questions
Does Arrowhead Pharmaceuticals have government contracts?
No federal prime contract obligations are matched to Arrowhead Pharmaceuticals (ARWR) in USAspending.gov for the last five years. Subcontracts are not included.
Where does the contract data come from?
USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.
What geopolitical news affects ARWR?
This page lists every Geopolitics Alpha note that names ARWR as exposed to an event, with the reason it is exposed.
Has Congress traded ARWR?
The table above lists trades in ARWR that members of Congress have publicly reported, with a link to each official filing.
Is this investment advice?
No. We show news, exposure and past price moves. Nothing here is a recommendation.